Poalim Medica III – a partnership between the leading VC teams at Medica Venture Partners and Poalim Capital Markets – is a $125 million dedicated healthcare and life science venture capital fund investing in Israeli and Israel-related companies. Its experienced general partners boast a successful track record, having served on the board of directors of more than 30 biotechnology and healthcare companies and having played a key role in the founding of several successful bioscience ventures. The fund is backed by a long-term, supportive investor base that includes George Soros, Teva Pharmaceutical, Baxter Laboratories, Boston Scientific and William Blair & Co.